Hunkapiller Michael 4

4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Mar 2, 2021

Insider Transaction Report

Form 4

Period: 2021-02-26

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.PACB

Hunkapiller Michael

Director

Transactions

Sale
Common Stock
2021-02-26$31.49/sh−43,946$1,383,991→ 867,881 total
Sale
Common Stock
2021-02-26$32.74/sh−15,771$516,311→ 852,110 total
Sale
Common Stock
2021-02-26$30.69/sh−170,824$5,242,076→ 911,827 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-26−45,134→ 0 total
Exercise: $5.27Exp: 2027-02-15→ Common Stock (45,134 underlying)
Exercise/Conversion
Stock Option (right to buy)
2021-02-26−79,363→ 0 total
Exercise: $7.87Exp: 2026-03-15→ Common Stock (79,363 underlying)
Exercise/Conversion
Common Stock
2021-02-26$7.87/sh+79,363$624,587→ 1,037,517 total
Exercise/Conversion
Common Stock
2021-02-26$5.27/sh+45,134$237,856→ 1,082,651 total
Sale
Common Stock
2021-02-26$33.33/sh−3,705$123,488→ 848,405 total
Exercise/Conversion
Stock Option (right to buy)
2021-02-26−109,749→ 0 total
Exercise: $5.72Exp: 2025-03-16→ Common Stock (109,749 underlying)
Exercise/Conversion
Common Stock
2021-02-26$5.72/sh+109,749$627,764→ 958,154 total

Footnotes (6)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2020.
[F2]This sale price represents the weighted average sale price of the shares sold ranging from $30.20 to $31.19 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F3]This sale price represents the weighted average sale price of the shares sold ranging from $31.20 to $32.18 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F4]This sale price represents the weighted average sale price of the shares sold ranging from $32.23 to $33.20 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F5]This sale price represents the weighted average sale price of the shares sold ranging from $33.23 to $33.43 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F6]The shares subject to the option are fully vested and exercisable.

Documents

1 file

4
certent-form4.xmlPrimary
PRIMARY DOCUMENT